Document is current

Any future updates will be listed below

Neue Zweitlinienoption für stark vorbehandelte MCL-Patienten

Crossref DOI link: https://doi.org/10.1007/s15015-025-4118-0

Published Online: 2025-02-07

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark